Tango Therapeutics (TNGX) Stock: Buy, Sell, or Hold?
TNGX - Tango Therapeutics, Inc.
$23.24
-1.21 (-4.95%)
âŧ
5d:
-6.74%
30d:
+4.12%
90d:
-22.38%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 03, 2026
30d
Get Alerted When TNGX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: TNGX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: TNGX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: TNGX is currently trading at $23.24, which is considered slightly low relative to its 30-day fair value range of $22.76 to $24.84.
Technical Outlook: Technically, TNGX is in a strong uptrend. Immediate support is located at $21.63, while resistance sits at $25.92. Short-term momentum is weak, with the stock down 4.9% recently.
Market Sentiment: TNGX scores 20/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $45.18 (+94.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TNGX is in a strong uptrend. Immediate support is located at $21.63, while resistance sits at $25.92. Short-term momentum is weak, with the stock down 4.9% recently.
Market Sentiment: TNGX scores 20/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $45.18 (+94.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$22.76 -
$24.84
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
Protect Your Profits
Holding TNGX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (20/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.9%)
- BULLISH: Trading 94.4% below Wall St target ($45.18)
- WARNING: Composite score 45/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$22.76 -
$24.84
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$21.63
Resistance Level
$25.92
Current Trend
Strong Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-13.79
Wall Street Target
$45.18
(+94.4%)
Revenue Growth (YoY)
-100.0%
Profit Margin
-229.9%
Share & Embed Analysis
Last updated: October 03, 2026 3:10 AM ET
Data refreshes hourly during market hours. Next update: 4:10 AM
Data refreshes hourly during market hours. Next update: 4:10 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TNGX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Adam Crystal
SELL
38460 shares
2026-04-15
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical âĻ |
STRONG BUY
29 analysts |
$92 | 46 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$36 | 65 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$109 | 76 BUY |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$34 | 65 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$285 | 42 HOLD |
Advanced TNGX Option Strategies
Professional options setups generated by AI based on today's TNGX price and gamma walls.
